Loss of 1p36 and CpG methylation of the miR-34a promoter leads to BC tumorigenesis by inhibiting cancer cell invasion, both in vitro and in vivo, and inhibiting fos-related antigen-1 in BC cells [42,43]. The gene discussed is FOSL1; the disease is cancer.